TP53 and familial pancreatic carcinoma: In Rajeshkumar’s work, treatment of pancreatic cancer cells carrying mutated TP53 with FX11, a small molecule inhibitor of LDHA, was revealed to have decreased metabolic activity, increased apoptosis, and attenuated tumor growth (42).